Moneycontrol PRO
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsIndia

Keeping close watch on COVID-19 situation in Delhi, no need to panic, says Arvind Kejriwal

Delhi reported a positivity rate of 2.70 per cent on Monday, the highest in the last two months, triggering concerns about the resurgence of Covid in the capital. The test positivity rate stood at 2.87 per cent on February 5.

April 12, 2022 / 01:06 PM IST
Arvind Kejriwal (Image: ANI)

Arvind Kejriwal (Image: ANI)

Delhi Chief Minister Arvind Kejriwal on Tuesday said his government is keeping a close watch on the Covid situation in the capital and there is no major reason to panic at present. He said all necessary steps will be taken if the need arises.

Delhi reported a positivity rate of 2.70 per cent on Monday, the highest in the last two months, triggering concerns about the resurgence of Covid in the capital. The test positivity rate stood at 2.87 per cent on February 5.

"We are keeping a close watch on the situation. There's no major reason to panic right now. We will take all necessary steps according to the situation," Kejriwal told reporters here.

With the positivity rate jumping from 0.5 per cent on April 4 to 2.70 percent on Monday, Delhi Health Minister Satyendar Jain had said the city government is keeping a watchful eye on the COVID-19 situation and there is no reason to worry until a new variant of concern is detected.

"The daily cases in Delhi are being reported in the range of 100-200. We are keeping an eye on hospital admissions and they are going down. Focus shouldn't be on positivity rate much as of now," Jain had said on Monday.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
(With PTI inputs)
Moneycontrol News
first published: Apr 12, 2022 01:06 pm